3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Oropharyngeal Neoplasms
4
Head and Neck Neoplasms
3
Lung Neoplasms
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Rectal Malignant Neoplasms
1
Radiation Injuries
1
Postoperative Complications
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Mouth Neoplasms
1
Low Anterior Resection Syndrome
1
Laryngeal Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
HPV-Related Squamous Cell Carcinoma
1
Fatigue
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Interventions
pembrolizumab
57
Nivolumab
50
Ipilimumab
31
Specimen Handling
23
Magnetic Resonance Spectroscopy
19
Cyclophosphamide
14
Biopsy
11
fludarabine
10
binimetinib
10
Opdualag
10
trametinib
9
relatlimab
9
Radiosurgery
9
CTLA-4 Antigen
9
dabrafenib
8
lifileucel
7
fludarabine phosphate
7
aldesleukin
7
encorafenib
6
Interleukin-2
6
cemiplimab
5
atezolizumab
5
Paclitaxel
5
Blood Specimen Collection
5
X-Rays
4
Taxes
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
Carboplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Chemoradiotherapy
×
90 days
×
Clear all
No trials found.